Cellosaurus logo
expasy logo

Cellosaurus 585A1-C7 #3-3 (CVCL_C1G0)

[Text][XML][JSON]
Cell line name 585A1-C7 #3-3
Synonyms 585A1-C7-retained #3-3; C7 #3-3
Accession CVCL_C1G0
Resource Identification Initiative To cite this cell line use: 585A1-C7 #3-3 (RRID:CVCL_C1G0)
Comments Population: Japanese.
Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4933; HLA-C (Note=1 of 2 alleles: C*12:02, leaving C*07:01 intact).
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_DQ06 (585A1)
Sex of cell Male
Age at sampling 30-39Y
Category Induced pluripotent stem cell
Publications

PubMed=30853558; DOI=10.1016/j.stem.2019.02.005
Huai-Geng Xu, Bo Wang, Miyuki Ono, Akihiro Kagita, Kaho Fujii, Noriko Sasakawa, Tatsuki Ueda, Peter Gee, Misato Nishikawa, Masaki Nomura, Fumiyo Kitaoka ...Show all 16 authors... , Tomoko Takahashi, Keisuke Okita, Yoshinori Yoshida, Shin Kaneko, Akitsu Hotta; Show fewer authors
Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility.
Cell Stem Cell 24:566-578.e7(2019)

Patent=US20200407693
Akitsu Hotta, Huai-Geng Xu, Shin Kaneko, Bo Wang;
Method for producing low-antigenic cell.
Patent number US20200407693, 31-Dec-2020

Cross-references
Encyclopedic resources Wikidata; Q114310461
Entry history
Entry creation22-Sep-2022
Last entry update19-Dec-2024
Version number6